Andrew Reardon - CLO & Secretary at LIGAND PHARMACEUTICALS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
CLO & Secretary
Issuer Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
All Insider Reports
All Insider Reports

Andrew Reardon - trading volume in the past year for LIGAND PHARMACEUTICALS INC

Holdings reported by Andrew Reardon for LIGAND PHARMACEUTICALS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 36,869 $6,777,628 $183.83 15 Feb 2026 Direct
Employee Stock Option (right to buy) 28,043 04 Mar 2025 Direct Common Stock

Transactions reported by Andrew Reardon for LIGAND PHARMACEUTICALS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.